This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Hepatitis A is a highly contagious liver infection caused by the hepatitis A virus (HAV). It is spread through contact with contaminated food or water and can also be spread through close contact with someone who is already infected. Symptoms typically include fever, fatigue, loss of appetite, nausea, abdominal pain, and jaundice. Most people who are infected with HAV recover completely and do not have any long-term health problems. Hepatitis A is primarily spread through contact with objects, food or drinks that have been contaminated with the virus. Common sources of infection include contaminated water, food that has been prepared by someone with the virus, and contact with an infected person. People who are at an increased risk of infection include travelers to regions with high rates of hepatitis A, those who use injection drugs, and men who have sexual contact with other men. The most effective way to protect yourself from hepatitis A is to get vaccinated. The hepatitis A vaccine is recommended for all children at age 12 months, as well as for adults who are at an increased risk of infection. Good hand hygiene is also important in helping to prevent the spread of the virus. Hepatitis A can be treated with medications that can help reduce symptoms and shorten the duration of the illness. It is important to talk to your healthcare provider to find out what treatment is right for the patient.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States